Urology Devices Market Share

Global Urology Devices Market Overview

The urology devices market size was valued at USD 36.5 billion in 2022 and is projected to grow from USD 37.96 Billion in 2023 to USD 48.5 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4% during the forecast period (2023 - 2032). Increased health consciousness and expenditure are the key market drivers enhancing market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

In August 2023 saw Fresenius Medical Care AG & Co. KGaA (Germany) announce FDA Clearance for Versi HD with GuideMe Software as a product.Teleflex Incorporated, for example, announced the acquisition of Palette Life Sciences, Inc., a medical device manufacturer, in July 2023 to enhance the firm’s urological devices portfolio. These instances are, therefore, likely to boost market growth over the forecast period.

In February 2023, Ethicon, Inc. reported the first use of robotic-assisted kidney stone removal with the Monarch platform. This technique helps decrease retreatment rates after kidney stone removal and reduce complications and risk rates.

In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced that Boston Scientific would make a partial offer to acquire up to a maximum of 65% stake in shareholding of Acotec, which is a Chinese medical technology company offering solutions designed for various interventional procedures).

In December 2022, Alleima acquired ENDOSMART, which is involved in the development and production of nitinol-based medical devices and components. The company mainly serves companies that develop medical devices for oncology, urology, cardiology vascular application as well as orthopedics. With this acquisition, Alleima aims to improve its healthcare service provision.LiNA Medical partnered with UroCure in September 2021 to develop surgical treatment solutions for female stress urinary incontinence.

Advanced Medtech led Devicare's USD 3 million Series A fundraising round in January 2021, aimed at bringing digitalized management medical devices and urological services into the market. Advanced MedTech's strategic investment will complement its existing product line while strengthening its leadership position in urology and kidney stone management.

In July 2021, Boston Scientific announced in July 2021 that it has started selling LithoVue Empower Retrieval Deployment Device, which is a minimally invasive instrument meant to facilitate the process of removing kidney stones when undertaking ureteroscopic lithotripsy surgeries.

Cook Medical achieved FDA clearance for the Zenith Alpha thoracic endovascular grafting system in June 2021. It is applied during minimally invasive treatment of thoracic aortic aneurysms and dissections.

Urology Devises Market Trends

• Increasing Prevalence of Kidney Disorders to Fuel Market Growth

The increasing prevalence of kidney diseases, such as chronic kidney disease and renal failure, is a major factor in the increasing adoption of dialysis machines worldwide. For instance, the 2021 annual report for Fresenius Medical Care estimates that the number of people with chronic kidney disease will be about 3.8 million in 2022 and more than 6 million by 2030.

In addition, demand for dialysis products such as dialysate and hemodialysis machines increased due to the large number of patients undergoing dialysis treatment. As a result, manufacturers are launching urological devices, thereby driving market growth. Furthermore, new product launches and the rising prevalence of kidney disorders are anticipated to surge the patient population seeking dialysis treatment, driving the market CAGR.

Figure 1: Percentage of US Adults Aged 18 Years or Older With CKD (in %)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

The increasing prevalence of numerous urological-related diseases, such as urolithiasis, urethral malignancies, chronic kidney disease, and end-stage renal disease, has driven healthcare providers and manufacturers to adopt technologically advanced urological devices. We are now strengthening our research and development. For example, in May 2021, UCI Health urologists tested a new laser technology. It surprised thulium fiber laser shrinks large kidney stones to a smaller size, allowing them to be easily aspirated or flushed from tshe body. Such effort in research studies is anticipated to propel the urology devices market revenue over the forecast period.

Urology devices Market Segment Insights

Urology devices Type Insights

Based on type, the market segmentation of urology devices includes dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The endoscopy devices segment held the majority share in 2022 with respect to the market revenue of urology devices attributed to the increasing prevalence of urolithiasis and the high demand for disposable cystoscopes, especially in developed countries. Furthermore, surged patient calls to urology clinics attached to the growing adoption of dilators and catheters in the urology clinics for handling are anticipated to give to segmental growth during the forecast period.

Urology devises Application Insights

The urology devices market data has been bifurcated by application into Minimally Invasive Surgery and Robotic Surgery. The minimally invasive surgery segment dominated the market in 2022. The terminal side segment is proposed to be the fastest-growing segment during 2023-2030, attributed to the increasing number of patients suffering from urological disorders choosing minimally invasive processes over traditional ones.

Urology devises Service Technology Insights

Based on technology, the Urology Devices market segmentation includes benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. The urinary incontinence Urology Devices segment held the majority share in 2022 with respect to the market revenue of Urology Devices due to the owing to Diabetic patients having a higher risk of developing urinary incontinence.

September 2021:LiNA Medical partnered with UroCure to develop surgical solutions for female stress urinary incontinence.

Urology devises End-User Insights

Based on end-user, the market for urology devices includes hospitals and ambulatory services. The hospitals and clinics led the market in 2022 and are projected to be the faster-growing segment during the forecast period, 2023-2030, due to the growing number of patient appointments in hospitals with urology-related disorders. Moreover, the rising adoption of urology endoscopes such as ureteroscopy and cystoscope devices for ongoing treatment and diagnosis is expected to drive segmental growth during the forecast timeframe. Hence, rising End-User options for Urology Devices positively impact the market growth

Figure 2: Urology Devices Market, by End-User, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

By region, the study offers market insights into Asia-Pacific, North America, Europe, and Rest of the World. The North America Urology Devices market accounted for USD 16.71 billion in 2022 and is projected to grow at a significant CAGR growth during the study period, attributed to the Increasing number of patients suffering from kidney disease, increasing patient visits for treatment and diagnosis, and vital existence of market players in the region are projected to propel the market. Further, the United States market of urology devices held the largest market share, and the Canada market of urology devices was the fastest-growing market in the North American region.

Further, the major countries studied in the market report are: The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: UROLOGY DEVICES MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Urology Devices market accounts for the second-largest market share due to the Increasing number of patients suffering from kidney disease, rising patient visits for treatment and diagnosis, and the strong presence of key market players in the region are expected to drive the market. In addition, the rapid adoption of disposable cystoscopes and the increasing launch of technologically advanced urological devices by key market players are anticipated to propel market growth in this region. Key players in Europe are placing more emphasis on introducing advanced urological devices to improve operational efficiency, which is also playing an important role in the market's growth. Moreover, the UK market of urology devices held the largest market sharenwhereas Germany market of urology devices is the fast growing in the region.

The Asia-Pacific Urology Devices Market is projected to develop at the fastest CAGR from 2023 to 2030 due to increasing focus on improving growing awareness regarding the diagnosis of urology disorders, healthcare infrastructure, and rising product launches by companies across Japan, China, and India. Furthermore, increased government investments in developing advanced healthcare infrastructure are likely to boost ventilator usage across the region's hospital facilities that supplement the market growth. Key players are devising market entry strategies to expand their business presence in the Asia Pacific. Moreover, the China market of urology devices held the largest market sharenwhereas India market of urology devices is the fast growing in the Asia-Pacific region.

Urology devises Key Market Players & Competitive Insights

Key market players are spending significant funds on research and development to expand their product lines, which will help the urological devices market to grow further. Market players are also adopting various strategies to expand their footprint through important market developments such as contractual agreements, new product launches, mergers and acquisitions, increased investments, and collaborations with other organizations. taking the initiative. Competitors in the urology device industry need to expand their business presence to compete in an increasingly competitive and growing market environment.

One of the key business strategies industries adopted in urology device manufacturing to benefit clients and expand the market sector is increasing investment in R&D to enhance solutions and services. In recent years, the Urology Devices industry has provided transparency and reduced disruptions in the supply chain. The Urology Devices market major players such as Boston Scientific Corporation, Olympus Corporation, Medtronic, R. Bard, KARL STORZ GmbH & Co. KG, and others are functioning to further expand the market growth by investing in research and development activities.

Olympus is a Japanese company that develops customer-centric solutions for the medical, life sciences and industrial equipment industries. Olympus has focused on making people's lives healthier, safer and more fulfilling by helping diagnose, prevent and treat disease, advance scientific research and ensure public safety. For example, in July 2020, Olympus Corporation introduced the Soltive SuperPulsed Laser System in the United States as an option for urologists to use in lithotripsy and soft tissue applications.

Boston Scientific Corporation is a US-based biomedical/biotechnology engineering company specializing in interventional radiology, interventional cardiology, peripheral intervention, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, Multinational manufacturer of medical devices used in interventional medical specialties such as vascular surgery, endoscopy and oncology. , Urology, Gynecology. For example, in March 2021, Boston Scientific Corporation entered into a definitive agreement with a subsidiary of BPEA (Baring Private Equity Asia) to acquire Lumenis LTD's surgical business. This business includes urology and ENT products such as premium laser systems, fibers and accessories for urology.

Key Companies in the Urology Devices market include

• KARL STORZ GmbH & Co. KG


• Olympus Corporation


• Medtronic


• Boston Scientific Corporation


• R. Bard


• Fresenius Medical Care AG & Co. KGaA (Germany)


• Dornier MedTech (Germany)


• Stryker (US)

Urology devises Industry Developments

January 2021:Advanced Medtech led Devicare's USD 3 million series A fundraising event to bring digitalized management medical devices and urological medical to market. Devicare's strategic investment adds to Advanced MedTech's product portfolio and improves its position as a leader in urology and kidney stone management

February 2019:Coloplast and Premier Inc signed a three-year agreement for its urology products. The general urological products include drainage systems, catheters, and other accessories, thereby increasing penetration of the product in a new market.

Urology devises Market Segmentation

Urology devices Type Outlook

• Dialysis Equipment


• Urinary Stone Treatment Devices


• Endoscopy Devices


• Benign Prostatic Hyperplasia Treatment Devices


• Urinary Incontinence & Pelvic Organ Prolapsed

Urology Devices Application Outlook

• Minimally Invasive Surgery


• Robotic Surgery

Urology Devices Technology Outlook

• Benign Prostatic Hyperplasia


• Prostate Cancer


• Urinary Stones


• Urinary Incontinence

Urology Devices End-User Outlook

• Hospitals


• Ambulatory Services

Urology Devices Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America